Press release: Uniogen Appoints Christine Richter, PhD, MBA, to Its Board of Directors

Uniogen has appointed Christine Richter, PhD, MBA, to its Board of Directors following the company’s Annual General Meeting, further strengthening the company’s expertise in oncology, biotechnology and international commercialization. With nearly two decades of leadership experience in the biopharmaceutical industry across Europe and the United States, Dr. Richter brings extensive strategic, scientific and operational expertise to support Uniogen’s continued growth in cancer diagnostics. Her appointment reflects Uniogen’s ambition to accelerate the development and commercialization of innovative oncology diagnostics while expanding its international presence.